Drug intelligence / Profile preview

povidone-iodine + rifampicin

Development stage: Unknown
Lead developer: Elif Asena KANTARCI
Modality: Small Molecules
Administration: Topical

Overview

povidone-iodine + rifampicin is a combination antiseptic and antibiotic solution being evaluated for preoperative scalp antisepsis. Developed by investigator Elif Asena KANTARCI, the formulation combines 10% povidone-iodine, a broad-spectrum antiseptic that releases free iodine to oxidize microbial proteins and nucleic acids, with 125 mg of rifampicin, an antibiotic that inhibits bacterial DNA-dependent RNA polymerase. This combination is specifically intended to reduce the incidence of surgical site infections and enhance wound healing in patients undergoing hair transplantation procedures by providing synergistic antimicrobial activity against common scalp flora.

Other names: Povidone-Iodine 10% + Rifampicin 125mgRifampicin and Povidone-Iodine for Scalp Antisepsis

Targets

rpoB (DNA-directed RNA polymerase subunit beta)

Beyond the preview

Go deeper on povidone-iodine + rifampicin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on povidone-iodine + rifampicin.

Explore the full profile